SUMMARY PARAGRAPH for NEO1
S. cerevisiae has five genes encoding type 4 P-type ATPases: NEO1, DRS2, DNF1, DNF2, and DNF3. The "P-type" designation indicates that these integral membrane proteins form a covalent aspartyl-phosphate catalytic intermediate during ATP hydrolysis (2 and references therein). Most P-type ATPases mediate the transport of small cations across biological membranes. However, members of the "type 4" subfamily are aminophospholipid translocases (flippases), rather than cation transporters, and move phospholipids from one side of a membrane bilayer to the other (reviewed in 5). Of the five S. cerevisiae type 4 P-type ATPases, only NEO1 is essential. Although the four other genes appear to have substantial functional overlap (any single DRS2/DNF gene confers cell viability) (2), they are distinct in their localization, specificity, and cofactor association.
Neo1p localizes primarily to endosomes and the Golgi apparatus, where it contributes to endocytosis and vacuolar biogenesis (3, 4). Because of the essential nature of this gene, Neo1p aminophospholipid translocase activity has not yet been experimentally demonstrated and substrate specificity is not currently known. Neo1p is associated with Mon2p (4), a Sec7p-family protein that shares very little sequence similarity with the non-catalytic subunits of other S. cerevisiae type 4 P-type ATPases.
The P-type ATPase superfamily is evolutionarily conserved, but the type 4 subfamily is found only in eukaryotes. Fourteen type 4 P-type ATPases have been characterized in humans (5 and references therein), including the DRS2 homolog, ATP8A1 (aka ATPase II) (6) and the DNF1/DNF2 homolog ATP8B1 (aka FIC1) (2). Mutations in ATP8B1 result in progressive familial intrahepatic cholestasis (Byler disease), benign recurrent intrahepatic cholestasis (BRIC), and intrahepatic cholestasis of pregnancy (ICP).
Last updated: 2007-03-01